S
Sebhat Erqou
Researcher at Brown University
Publications - 96
Citations - 7086
Sebhat Erqou is an academic researcher from Brown University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 68 publications receiving 5897 citations. Previous affiliations of Sebhat Erqou include Providence VA Medical Center & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
Sebhat Erqou,Stephen Kaptoge,P Perry,E Di Angelantonio,Alexander M. W. Cargill Thompson,Ian R. White,Santica M. Marcovina,Rory Collins,Simon G. Thompson,John Danesh +9 more
TL;DR: Under a wide range of circumstances, there are continuous, independent, and modest associations of Lp(a) concentration with risk of CHD and stroke that appear exclusive to vascular outcomes.
Journal ArticleDOI
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
Kausik K. Ray,Sreenivasa Rao Kondapally Seshasai,Shanelle Wijesuriya,Rupa Sivakumaran,Sarah Nethercott,David Preiss,Sebhat Erqou,Naveed Sattar +7 more
TL;DR: Overall, intensive compared with standard glycaemic control significantly reduces coronary events without an increased risk of death, however, the optimum mechanism, speed, and extent of HbA(1c) reduction might be different in differing populations.
Journal ArticleDOI
Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
Alexander M. W. Cargill Thompson,Emanuele Di Angelantonio,Nadeem Sarwar,Sebhat Erqou,Danish Saleheen,Robin P. F. Dullaart,Bernard Keavney,Zheng Ye,John Danesh +8 more
TL;DR: Three CETP genotypes that are associated with moderate inhibition of CETP activity (and, therefore, modestly higher HDL-C levels) show weakly inverse associations with coronary risk.
Journal ArticleDOI
Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
Kausik K. Ray,Sreenivasa Rao,Kondapally Seshasai,Sebhat Erqou,Peter S. Sever,J. Wouter Jukema,Ian Ford,Naveed Sattar +7 more
TL;DR: This literature-based meta-analysis did not find evidence for the benefit of statin therapy on all-cause mortality in a high-risk primary prevention set-up.
Journal ArticleDOI
Burden of Undiagnosed Hypertension in Sub-Saharan Africa A Systematic Review and Meta-Analysis
Feven Ataklte,Sebhat Erqou,Stephen Kaptoge,Betiglu Taye,Justin B. Echouffo-Tcheugui,Andre P. Kengne +5 more
TL;DR: In this paper, a systematic review and meta-analysis was conducted to assess the recent burden of hypertension in Sub-Saharan Africa, based on studies published between 2000 and 2013. But only 7% of individuals with hypertension were receiving treatment across the studies, and only 6% of those with hypertension had controlled blood pressure.